In this study, we analyzed the microarray datasets downloaded from the NCBI-GEO database of glioblastoma xenografts that developed a resistance against bevacizumab treatment and compared them with glioblastoma xenografts without bevacizumab treatment to examine whether the gene expression differed during the development of resistance to anti-VEGF therapy. The gene discussed is VEGFA; the disease is glioblastoma.